论文部分内容阅读
作者曾发现慢性酒精中毒者服用1片(0.5克)四乙基秋兰姆化二硫(tetraethylthiuram disulfide,简写TTD,即Disulfiram)后,二乙基二硫代氨基甲酸酯(DDC)的排出量有明显的个体差别,并认为这主要是由于个体对此药物的代谢差异所引起的。由此作者认为值得进一步研究接触二硫化碳工人口服TTD后的DDC排出量,以期找出衡量对二硫化碳感受性的方法。受试工人口服1片(0.5克)TTD后,
The authors have found that the release of diethyldithiocarbamate (DDC) from chronic alcoholism patients after taking one tablet (0.5 gram) of tetraethylthiuram disulfide (abbreviated TTD, Disulfiram) There are significant individual differences and this is mainly due to the individual’s metabolic differences caused by the drug. The author therefore believes it is worth further studying DDC emissions from oral carbon disulfide workers exposed to TTD in an effort to find ways to measure their susceptibility to carbon disulfide. After the test workers orally take 1 tablet (0.5 g) TTD,